Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension. (2021)

First Author: Alves-Lopes R
Attributed to:  Capacity Building in Redox Biology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/hypertensionaha.121.17041

PubMed Identifier: 34304582

Publication URI: http://europepmc.org/abstract/MED/34304582

Type: Journal Article/Review

Volume: 78

Parent Publication: Hypertension (Dallas, Tex. : 1979)

Issue: 3

ISSN: 0194-911X